Quality Standards
In a survey conducted by Nature, 90% of respondents agreed that there was a reproducibility crisis in biological experiments. Many blamed it on poor-quality antibodies. Irreproducible results not only frustrate researchers, they also waste precious time, samples, and funding.
At HUABIO, we refuse to create antibodies that contribute to this problem and instead are continuously working to provide the solution. We constantly develop consistent, high-quality antibodies for the purpose of advancing innovation. We're always challenging ourselves to be more efficient and accurate while routinely evolving our products for researchers all over the world.
What We Do Differently
Stability
We examined the stability of our antibodies at different storage temperatures for varying lengths of time to verify the stability and quality of antibodies during transportation and storage. We have demonstrated that with a subset of our antibodies, room temperature does not impair their activity for up to three months.
Product shown:
Beta-Actin Monoclonal Antibody
[EM21002] 1:10,00
Sample used:
PC-12 whole cell lysates
Specificity
Knockout (KO) validation is used to confirm antibody specificity by testing the antibody of interest in a KO cell line or tissue that does not express the target protein. No signal is observed when a specific antibody is tested in a KO cell line while giving the specific target protein signal in the wild-type (WT) cell line.
Product shown:
ATP Citrate Lyase Recombinant Monoclonal Antibody
[ET1609-37] 1:1,000
Lot-to-Lot Consistency
As an antibody manufacturer, we evaluate each and every new lot. After each lot has been successfully produced, we compare the newest batch to the previous. We use the same experimental conditions to review whether the activity and specificity remain consistent.
Product shown:
PAX8 Recombinant Monoclonal Antibody
[ET1701-50] 1:50
Sample used:
SK-OV-3 whole cell lysates
In addition to the validation and reliablilty we actively test for, we have dedicated our new production capacity to recombinant antibodies. We also plan to transform all other high-performing polyclonal and hybridoma monoclonal antibodies onto the recombinant platform.
We don't shy away from the extra processes or steps that need to be taken in order to produce the most consistent products for you and your lab. Our quality standards have one goal: reliable, reproducible results for every researcher the first time and every time.